Fennec Pharmaceuticals Inc. · NASDAQ:FENC
Solas Capital Management, LLC's stake in Fennec Pharmaceuticals Inc. fell to 4.10% (Schedule 13G/A)
Event Sep 30, 2026 · Filed Nov 16, 2026
Solas Capital Management, LLC's stake in Fennec Pharmaceuticals Inc. fell to 4.10%, 1,433,282 shares, as a passive investor on Sep 30, 2026. Filed Nov 16, 2026 (Schedule 13G/A).
- Stake
- 4.10%
- Shares
- 1,433,282
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Solas Capital Management, LLC | 4.10% | 1,433,282 |
| FREDERICK TUCKER GOLDEN | 4.10% | 1,433,282 |
Source
Download original · View original at SEC
Related
- Fennec Pharmaceuticals Inc.
- Solas Capital Management, LLC
- Fennec Pharmaceuticals Inc. shareholders
- Schedule 13G/A · Solas Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Solas Capital Management, LLC · May 15, 2026
- Schedule 13G/A · Solas Capital Management, LLC · Feb 14, 2025
- Form 4 · Brughera Marco Maria · Nov 16, 2026
- Schedule 13G/A · Lawrence Kam · Nov 16, 2026
- Form 4 · Cioffi Christiana Marie · Nov 2, 2026
- Form 4 · Andrade Robert · Nov 2, 2026
- Form 4 · Evans Terry L · Nov 2, 2026